Prospera Financial Services Inc Jazz Pharmaceuticals PLC Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$114.26 - $136.0 $1,485 - $1,768
13 Added 0.62%
2,122 $261,000
Q3 2023

Nov 13, 2023
SELL
$122.0 - $145.31 $2,318 - $2,760
-19 Reduced 0.89%
2,109 $272,000
Q2 2023

Aug 08, 2023
BUY
$122.5 - $147.16 $260,680 - $313,156
2,128 New
2,128 $263,000
Q2 2022

Aug 08, 2022
SELL
$141.59 - $168.66 $77,024 - $91,751
-544 Reduced 6.75%
7,521 $1.17 Million
Q1 2022

May 04, 2022
BUY
$129.64 - $160.7 $1.05 Million - $1.3 Million
8,065 New
8,065 $1.26 Million

Others Institutions Holding JAZZ

# of Institutions
511
Shares Held
57.8M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email